Based on potential benefits to human health, there is increasing interest in altering the composition of ruminant-derived foods. Including rapeseeds in the dairy cow diet is an effective strategy for replacing medium-chain saturated fatty acids (SFA) with cismonounsaturated fatty acids (MUFA) in bovine milk, but there is limited information on the optimum level of supplementation. Decreases in SFA due to plant oils are also accompanied by increases in milk trans fatty acid (FA) content and it is possible that high oleic acid rapeseeds may result in a higher enrichment of cis-9 18:1 and lower increases in trans FAs in milk compared with conventional varieties. Seven multiparous lactating Holstein-Friesian cows were allocated to one of seven treatments in an incomplete Latin square design with five 28-day experimental periods, to evaluate the effect of replacing calcium salts of palm oil distillate (CPO; 41 g/kg diet dry matter, DM) with 128, 168 or 207 g/kg diet DM of conventional (COR) or a high oleic acid (HOR) rapeseed fed as a supplement milled with wheat. Rapeseed variety and inclusion level had no effect ( P . 0.05) on DM intake, milk yield and composition. Both rapeseed varieties decreased linearly ( P , 0.001) milk fat SFA content, which was partially compensated for by a linear increase ( P , 0.001) in cis-9 18:1 concentration. Reductions in milk SFA were also associated with increases ( P , 0.05) in trans 18:1 and total trans FA content, with no difference ( P . 0.05) between rapeseed varieties. Replacing CPO in the diet with milled rapeseeds had no effect ( P . 0.05) on total milk conjugated linoleic acid (CLA) concentration. Relative to a COR, inclusion of a high oleic acid variant in the diet increased ( P 5 0.01) the ratio of trans-MUFA : trans-polyunsaturated fatty acids in milk that may have implications with respect to cardiovascular disease risk in humans. In conclusion, data indicated that replacing CPO with milled rapeseeds at levels up to 1150 g oil/day could be used as a nutritional strategy to lower milk SFA content without inducing adverse effects on DM intake and milk production. HOR reduced milk fat SFA content to a greater extent than a conventional variety, but did not minimise associated increases in trans FA concentrations. However, the high oleic acid variant did alter the relative abundance of specific trans 18:1, CLA and trans 18:2 isomers compared with conventional rapeseeds.
Introduction
Clinical and biomedical studies have shown that cardiovascular disease (CVD) risk factors can be improved by the isoenergetic replacement of saturated fatty acids (SFA) with -E-mail: k.e.kliem@reading.ac.uk cis-monounsaturated fatty acids (MUFA) in the human diet (Kris-Etherton et al., 1999; Mensink et al., 2003) . Milk and dairy products are the major source of SFA in the European diet (Hulshof et al., 1999; Henderson et al., 2003) . Rather than simply advocating population-wide decreases in milk and dairy product consumption, altering the FA composition of ruminant milk offers the opportunity to lower SFA intake while maintaining the contribution of these foods to highquality protein, bioactive lipid, mineral and vitamin supply in the human diet .
Numerous studies have shown the potential of oilseed and plant oil supplements in the diet to alter bovine milk FA composition (Glasser et al., 2008; Shingfield et al., 2008) . A recent review reported an average decrease in total SFA concentration in milk fat of almost 10 g/100 g FAs when cows consume just over 500 g rapeseed oil/day (average response from a number of studies; Glasser et al., 2008) . Larger decreases in SFA of almost 20 g/100 g of total FAs have been reported in milk from cows fed diets supplemented with 4.1 kg/day of crushed rapeseeds supplying 1.97 kg of rapeseed oil, but the changes in milk fat composition were accompanied by substantial reductions in nutrient intake and milk yield relative to the control diet (Givens et al., 2003) . Feeding high levels of supplemental fat to dairy cows can adversely affect rumen function and lower milk production (Palmquist, 1994; Lock and Shingfield, 2004) . Givens et al. (2009) concluded that rapeseed milled with wheat, which offers a practical solution for processing oilseeds on-farm with the added benefit of minimising oil losses during milling, represented the most ideal compromise for lowering milk fat SFA content and increasing cis-MUFA concentrations without affecting animal performance and minimising associated increases in milk fat trans FAs.
Including rapeseed-based supplements in the diet of lactating cows also increases milk trans FA concentrations (Loor et al., 2002; Rego et al., 2009) . Although some evidence suggests that trans FAs from ruminant-derived products may not exert as negative an effect on CVD risk as those from industrial sources (Jakobsen et al., 2006; Willett and Mozaffarian, 2008) , other evidence is inconsistent Brouwer et al., 2010) . Several varieties of rapeseed containing higher proportions of oleic acid and lower amounts of polyunsaturated fatty acids (PUFA) have been bred and commercialised primarily for use as industrial frying oils (Schierholt et al., 2000 and . High oleic acid rapeseed variants offer the potential to lower milk SFA content, enhance cis-9 18:1 concentrations and minimise increases in trans FAs compared with conventional rapeseeds. The apparent biohydrogenation of cis-9 18:1 in the rumen is not as high as that of 18:2n-6 and 18:3n-3 with the implication that high oleic acid variants would result in a greater proportion of dietary unsaturated FAs escaping the rumen compared with conventional rapeseeds. Furthermore, studies in grazing cows have shown that increases in milk trans FA concentrations due to plant oils are directly related to the ratio of PUFA : cis-9 18:1 in lipid supplements (Rego et al., 2009) , with the implication that oilseeds rich in cis-9 18:1 rather than PUFA would minimise the appearance of ruminal biohydrogenation intermediates in milk fat triacylglycerides.
Previous studies have examined the effects of high oleic acid rapeseed oil on milk fat composition (Jenkins, 1998; Loor et al., 2002) , but direct comparisons with conventional sources of rapeseed oil have not been reported. In addition, relatively few studies (Collomb et al., 2004; Givens et al., 2009; Rego et al., 2009 ) have examined the effect of dietary rapeseed inclusion on milk FA composition in sufficient detail to allow definitive conclusions on the impact of the distribution of trans FA isomers to be drawn. In this experiment, nutrient intake, milk production and milk FA composition responses to replacing calcium salts of palm oil distillate (CPO) with incremental amounts of milled conventional or high oleic acid rapeseeds were evaluated in high-yielding lactating cows fed maize silage-based diets.
Material and methods
Experimental design, animals and management A total of seven multiparous Holstein-Friesian cows of (mean 6 s.e.) live weight 633 6 18.3 kg, parity 5.6 6 0.53, 79 6 7.9 days in lactation and producing 44.7 6 1.39 kg milk/day were used. Animals were randomly allocated to one of seven treatments in an incomplete 7 3 7 Latin square design with five 28-day experimental periods (Table 1) . Cows were housed in individual tie stalls equipped with a rubber mattress and bedded with wood shavings. Clean water and trace mineralised blocks (Rockies (red), Tithebarn Ltd, Cheshire, UK) were available ad libitum. Cows were milked in situ at 0400 and 1600 h.
Experimental diets Diets were offered as total mixed rations (TMR; forage : concentrate ratio, 50 : 50 on a dry matter (DM) basis with the forage component consisting of maize silage and grass silage, 750 and 250 g/kg of forage DM, respectively). Treatments consisted of a control diet containing 41 g/kg DM of CPO (Megalac R , Volac International Ltd, Royston, UK) or the same C o w  1  2  3  4  5   1  COR2  HOR2  COR3  CPO  COR1  2  HOR3  COR1  HOR2  COR3  HOR1  3  HOR2  HOR1  CPO  COR1  COR3  4  COR3  CPO  HOR3  HOR1  COR2  5  HOR1  HOR3  COR2  HOR2  CPO  6  CPO  COR2  COR1  HOR3  HOR2  7  COR1  COR3  HOR1  COR2  HOR3 COR1, COR2 and COR3 5 conventional oleic acid rapeseed at three inclusion levels; HOR1, HOR2 and HOR3 5 high oleic acid rapeseed at three inclusion levels; CPO 5 calcium salts of palm oil distillate-based diet.
basal diet with CPO replaced by 35, 46 or 57 g/kg DM of lipid derived from two different rapeseed varieties milled with wheat. Wheat was used as a binding agent to facilitate the milling of rapeseeds and also prevent oil losses following the rupturing of the seed coat. The milled rapeseed blend was prepared by processing the whole seeds with wheat grain (50 : 50, fresh weight basis) in a machine, which uses a combination of hammer (12 mm) and roller mills (processor model AFM 998Q; Buschhoft, GmbH & Co, Ahlen, Germany). Rapeseed treatments were comprised of a mixture of conventional varieties (Mozart and Astrid; COR) or a high oleic acid rapeseed (Nexera 160; Dow AgroSciences LLC, Hitchin, UK) variant. Diets were formulated to be isoenergetic and isonitrogenous (Thomas, 2004) and supply 750, 1000 or 1250 g rapeseed oil/day assuming a predicted mean DM intake of 22 kg/day. Ingredients and chemical composition of the experimental diets are shown in Table 2 . Cows were offered diets as equal meals at 0830 and 1600 h. Feed refusals were removed and weighed before the morning milking. Wheat feed (GP Feeds Ltd, Cheshire, UK) declared composition (g/kg DM) as containing CP (175), NDF (400), starch and sugars (340) and ME 11.5 MJ/kg DM.
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Proprietary mineral and vitamin supplement (Rockies (Red), Tithebarn Ltd, Cheshire, UK) declared composition as containing 380 g/kg sodium and (mg/kg) magnesium (5000), iron (1500), cobalt (50), copper (300), iodine (150), manganese (200), zinc (300) and selenium (10).
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Regumaize 44 (SvG Intermol Ltd, Bootle, Merseyside, UK) declared composition (g/kg DM) as containing CP (440), water-soluble carbohydrates (550), ME 11.8 MJ/kg DM.
Rapeseed oleic acid content and milk fatty acids neutral detergent fibre, organic matter, crude protein (CP), water-soluble carbohydrates, ether extract, starch, metabolisable energy and FA determinations according to procedures described elsewhere by Kliem et al. (2008) . Milk yields were recorded twice daily for individual animals during the last 7 days of each experimental period. Samples of milk preserved with potassium dichromate (1 mg/ml; Lactabs, Thomson and Capper, Runcorn, UK) were collected during this period and submitted for fat, CP and lactose determinations based on infrared spectroscopy (Foss Electric Ltd, York, UK). Additional samples of unpreserved milk were collected during the last 24 h of each experimental period, stored at 2208C until composited according to milk yield and submitted for FA analysis.
Lipid in 1 ml milk and appropriate sample weight of forage, concentrate and lipid supplements was extracted and transesterified to fatty acid methyl esters (FAME) according to standard methods (Kliem et al., 2008) . The distribution of conjugated linoleic acid (CLA) isomers in milk FAME was determined by HPLC using four silver impregnated silica columns (ChromSpher 5 Lipids, 250 3 4.6 mm; 5 mm particle size, Varian Ltd, Oxford, UK) coupled in series using 0.1% (v/v) of acetonitrile in heptane as the mobile phase (Shingfield et al., 2003) . Isomers were identified using an authentic CLA methyl ester standard (O-5632, Sigma-Aldrich, YA-Kemia Limited, Helsinki, Finland) and chemically synthesised trans-9, cis-11 CLA . Identification was verified using cis-9, trans-11 CLA as a landmark isomer.
Milk FA composition was expressed as a weight percentage of total FAs using response factors derived from the analysis of a butter oil reference standard (CRM 164; Community Bureau of Reference, Brussels, Belgium). Concentrations of specific conjugated isomers in milk fat were calculated based on proportionate peak area responses determined by HPLC and the sum of trans-7, cis-9 CLA, trans-8, cis-10 CLA and cis-9, trans-11 CLA weight percentage determined as a single peak by gas chromatography.
Statistical analysis Intake, milk production and milk FA composition data were analysed using a general linear model with effects for cow, period and treatment (Statistical Analysis Systems software package version 8.2, SAS Institute, Cary, NC, USA). Treatment carry-over effects were also included in the statistical model but were removed when declared non significant (P , 0.10). Preplanned contrasts included (i) CPO v. COR1, (ii) CPO v. HOR1, (iii) linear component of the response to incremental amounts of milled conventional rapeseeds in the diet, (iv) linear component of the response to incremental amounts of milled high oleic acid rapeseeds in the diet and (v) comparison of mean responses to milled conventional and high oleic acid rapeseeds in the diet. Single degree of freedom contrasts were also included in the statistical model to test for the significance of non-linear (quadratic) components of the response to incremental amounts of both types of milled rapeseed supplements in the diet. Least square means are reported and treatment effects were considered significant at P , 0.05.
Results
Analysis of the milled rapeseed/wheat supplements confirmed the higher cis-9 18:1 content of HOR compared with COR (68 and 57 g/100 g FAs, respectively). Lipid derived from the COR supplement compared with the HOR supplement contained 16:0 (5 v. 4 g/100 g FAs), 18:0 (2 v. 2 g/100 g FAs), 18:2n-6 (20 v. 16 g/100 g FAs) and 18:3n-3 (8 v. 2 g/100 g FAs). The higher enrichment of cis-9 18:1 in HOR was therefore associated with a lower sum of 18:2n-6 and 18:3n-3 relative to COR (18 v. 29 g/100 g FAs). The total FA content of the COR and HOR supplements were 230 and 236 g/kg DM, respectively.
By design, all seven experimental diets were of similar chemical composition. However, total dietary FA content was increased with incremental inclusion of milled rapeseeds ( Table 1 ). The predominant FA in the CPO diet was 16:0 contributing to more than one-third of total FAs, whereas cis-9 18:1 was the major dietary FA for all other treatments. For each inclusion level, the amount of cis-9 18:1 in the diet was approximately 5 g/kg DM higher on the HOR than COR treatments. Increasing inclusion level of rapeseed also increased dietary 18:2n-6 and 18:3n-3 content, but the total amount of PUFA at each level of inclusion was consistently higher for COR than HOR treatments.
There was no effect (P . 0.05) of replacing CPO with milled rapeseeds on DM intake, milk yield, milk constituent content or output (Table 3) . FA intake varied in direct relation to milled rapeseed inclusion, with both varieties resulting in lower (P , 0.001) intake of 16:0 and 18:0 and higher (P , 0.001) intake of cis-9 18:1, 18:2n-6 and 18:3n-3 than the CPO diet. Intake of cis-9 18:1, 18:2n-6 and 18:3n-3 increased linearly (P , 0.001) with incremental milled rapeseed inclusion. Consumption of cis-9 18:1 was on average 117 g/day higher (P , 0.001) for cows fed HOR than COR treatments, whereas ingestion of PUFA was higher (P , 0.001) by cows fed the COR than HOR diets.
Replacing CPO with both rapeseed supplements altered milk FA composition changes that were characterised as a decrease (P , 0.01) in total SFA, mainly due to lowered (P , 0.001) 16:0 concentrations, and an increase (P , 0.05) in total cis-and trans-16:1, total 18:1 and total trans FA content (Table 4) . Furthermore, supplements of milled rapeseeds also resulted in a decrease (P , 0.001) in cis-9 16:1, 18:2n-6, trans-8, cis-10 CLA and trans-9, trans-11 CLA and an increase (P , 0.01) in 18:0, 20:0, cis-9 and -11 20:1 (Table 4) , cis (D9, 13 and 16) and trans (D6 to D9, 12 and 16) 18:1 (Table 5) , cis-9, trans-13 18:2 and trans-10, trans-15 18:2 (Table 6 ). Relative to the CPO treatment, the COR1 treatment resulted in specific changes in 13:0, 14:0, 18:3n-3, cis-12 18:1, trans-13, -14 18:1, cis-9, cis-15 18:2 and trans-10, cis-12 CLA concentrations, whereas the HOR1 diet increased (P , 0.01) milk trans-4 and trans-5 18:1 content compared with CPO (Table 5) .
Incremental inclusion of milled rapeseeds in the diet resulted in linear (P , 0.05) decreases in total short-and medium-chain SFA with between 4 and 14 carbon atoms, 16:0 and total SFA and elicited linear (P , 0.05) increases in 18:0, cis-9 18:1 and total cis-MUFA concentrations.
Kliem, Shingfield, Humphries and Givens
The decrease in milk fat 8:0 and trans-9 14:1 content was also non-linear (P , 0.05). Linear responses (P , 0.05) to incremental amounts of milled HOR were also observed for milk fat trans-16:1 (Table 4) , trans-4, -9 and -10 18:1 (Table 5) , 18:2n-6, cis-9, cis-15 18:2 and trans-9, cis-12 18:2 (Table 6 ), several isomers of CLA (Table 6 ) and 18:3n-3 (Table 4) concentrations.
The type of rapeseed in the diet also influenced milk FA composition. Milk from cows fed milled CORs contained higher (P , 0.05) 14:0, 16:0, 18:3n-3, <C14 FAs, total SFA (Table 4) , cis-12 18:1 (Table 5 ) and specific 18:2 isomers including 18:2n-6 and cis-9, cis-15 18:2 (Table 6 ) compared with milled HORs. In contrast, HOR treatments resulted in higher (P , 0.05) mean milk fat 18:0, 20:0, cis-20:1, cis-9 18:1, trans-4 18:1, trans-5 18:1 and trans-6-8 18:1 contents than the COR treatments. Increases in the 18:3n-3 content of milk from cows fed the COR diet resulted in a lower (P , 0.05) n-6 : n-3 ratio than the control and HOR treatments supplying the same amount of rapeseed oil.
Discussion
This experiment examined the effects of replacing CPO with incremental amounts of two varieties of milled rapeseeds on milk production and milk FA composition in high-yielding dairy cows fed a maize silage-based diet. Supplements of milled high oleic acid rapeseed and wheat contained lower concentrations of cis-9 18:1 relative to milled conventional rapeseed and wheat than anticipated. Previous studies have examined the effects of a rapeseed oil, which contained 77 g cis-9 18:1/100 g FAs in lactating cows (Jenkins, 1998; Loor et al. 2002) , whereas the cis-9 18:1 content of oil from high oleic acid mutants can vary from 70% to 81% total FAs (Schierholt et al., 2000) . No measurements of the lipid composition of whole rapeseeds were made in this study, but the oil of the 'Nexera' high oleic acid rapeseed variety typically contains 73 g cis-9 18:1 and 17 g of PUFA/100 g total FAs (Dow AgroSciences LLC).
Including both types of rapeseed in the diet even at the highest inclusion level supplying in excess of 1100 g oil/day had no significant effect on DM intake, milk yield or milk constituent composition compared with the CPO diet, with the exception of a marginal decrease in milk fat concentrations. Previous studies have shown that supplementing the diet with supplements providing 1000 g rapeseed oil/day have no significant impact on DM intake and milk yield of cows when compared with a control diet, (Chelikani et al., 2004; Givens et al., 2009 ), but may, depending on the composition of the basal diet, lower milk fat synthesis (Chelikani et al., 2004) . However, supplementing the diet with 1214 g/day of rapeseed oil in the form of whole cracked rapeseeds was shown to decrease DM intake, milk yield and fat yield in mid-lactation cows (Givens et al., 2003) . It is generally accepted that high levels of plant oils or oilseeds in the diet induce adverse effects on rumen function and cow performance (Palmquist, 1994; Lock and Shingfield, 2004) . Results from this study as well as earlier studies highlight that a form of lipid in the diet is an important determinant of the potential effects on intake and milk production. CPO 5 calcium salts of palm oil distillate-based diet; COR1, COR2 and COR3 5 conventional oleic acid rapeseed at three inclusion levels; HOR1, HOR2 and HOR3 5 high oleic acid rapeseed at three inclusion levels; DM 5 dry matter. Rapeseed oleic acid content and milk fatty acids Rapeseed oleic acid content and milk fatty acids CPO 5 calcium salts of palm oil distillate-based diet, COR1, COR2 and COR3 5 conventional oleic acid rapeseed at three inclusion levels, HOR1, HOR2 and HOR3 5 high oleic acid rapeseed at three inclusion levels; DM 5 dry matter.
Refers to the significance of five comparisons; 1 -CPO diet v. COR diet level 1; 2 -CPO diet v. HOR diet level 1; 3 -linear response to COR inclusion level; 4 -linear response to HOR inclusion level; 5 -average of COR diet responses v. average of HOR responses. *, ** and ***P , 0.05, P , 0.01 and P , 0.001, respectively. 
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Ground rapeseeds have been shown to reduce fat corrected milk yield, milk fat and protein content in the absence of changes in DM intake (Chichlowski et al., 2005) . However, supplements of milled rapeseeds and wheat were reported to stimulate higher DM intake compared with the same amount of lipid in the diet as rapeseed oil (Givens et al., 2009) . Overall, available data suggest that inclusion of milled rapeseeds in the diet minimises potential negative effects of rapeseed oil on rumen function and animal performance. Replacing CPO with both rapeseed varieties resulted in a decrease in milk fat 16:0 and total SFA content. This is partially due to the presence of a palm oil-based rumen-protected lipid supplement in the CPO ration that was used to ensure that treatments were isoenergetic. However, earlier studies have shown that compared with a diet control containing no additional lipid, rapeseed oil lowers milk fat 16:0 and total SFA concentrations (Collomb et al., 2004; Ryhä nen et al., 2005; Rego et al., 2009) , indicating that irrespective of the composition of the basal diet, rapeseed-based lipid supplements can be expected to decrease milk SFA content. Rapeseed oil in the diet leads to an increase in long-chain unsaturated FAs available for absorption in the small intestine of lactating cows (Loor et al., 2002) leading to an inhibition of FA synthesis de novo in the mammary gland (Chilliard et al., 2000) . In this study, rapeseed inclusion did not appear to affect other short-and mediumchain SFA concentrations, although the COR1 treatment increased milk fat 14:0 content compared with the CPO diet.
Incremental inclusion of rapeseeds in the diet resulted in a linear decrease in milk SFA concentrations, 16:0 in particular, with no evidence that the changes in milk FA composition reached a plateau under the specified conditions of this experiment. Furthermore, marginal decreases in milk SFA content were greater for the HOR compared with the COR rapeseed with HOR treatments resulting in lower milk fat concentrations of SFA synthesised de novo and higher 18:0 concentrations. It is probable that the differences in the extent of changes in milk SFA due to rapeseed variety is at least in part due to a concentration effect, as HOR treatments induced a higher enrichment of cis-9 18:1. It is also possible that the larger decreases in milk SFA concentration following HOR rapeseed supplementation reflects direct competition between cis-9 18:1 and newly synthesised SFA for esterification with glycerol at the sn-2 and sn-3 during mammary triacylglycerol synthesis (Hansen and Knudsen, 1987) .
Despite diets containing rapeseeds resulting in a lower 18:0 intake than the CPO diet, both COR and HOR treatments enhanced milk fat 18:0 concentration. This can be explained by rapeseed diets resulting in a higher 18-carbon unsaturated FA intake than the CPO diet, which, following complete hydrogenation in the rumen (Harfoot and Hazlewood, 1997) increases the availability of 18:0 for absorption in the bovine small intestine. Post-ruminal flow of 18:0 has been found to be approximately 11 times greater than intake (on a g/day basis) in lactating cows fed diets containing rapeseed oil (Loor et al., 2002 ). An increase in milk 18:0 concentrations is a typical response to dietary rapeseed supplements (Givens and Shingfield, 2006; Glasser et al., 2008) .
Replacing CPO with rapeseed enhanced cis-MUFA in milk fat. The second most abundant cis-MUFA, cis-9 16:1, had a lower concentration in milk fat from cows consuming rapeseed diets when compared with the CPO diet, which is in agreement with earlier studies examining the effect of rapeseed in the diet in lactating cows (DePeters et al., 2001; Collomb et al., 2004) . A lower concentration of cis-9 16:1 can be attributed to decreased supply of 16:0 available for conversion to cis-9 16:1 via the action of D 9 -desaturase in the mammary gland. Use of 13 C-labelled FA substrates indicate that around 50% cis-9 16:1 secreted in milk is synthesised endogenously via the action of D 9 -desaturase on 16:0 (Mosley and McGuire, 2007) .
Enhanced cis-MUFA concentration in milk fat from all of the rapeseed diets was primarily due to increases in cis-9 18:1 concentration. This can be explained by an increased intake of cis-9 18:1, and also due to increased mammary availability of 18:0, which is desaturated at the mammary gland level. Around 50% of 18:0 taken up by the mammary gland is desaturated (Enjalbert et al., 1998) , and all studies examining responses to supplemental rapeseeds or rapeseed oil in the diet report an increase in milk cis-9 18:1 concentration (Givens and Shingfield, 2006; Glasser et al., 2008) . Increases in milk fat cis-9 18:1 concentrations to both rapeseeds were linear across the range of supplements fed in this experiment, indicating the potential to further enhance milk cis-9 18:1 content. Rapeseed inclusion also increased the concentration of several other cis-18:1 (D13 and 16) isomers. It is probable that these FAs originate from the rumen as a result of incomplete biohydrogenation of 18:3n-3 contained in rapeseeds (Jouany et al., 2007) .
Addition of both rapeseed types to the diet resulted in numerical increases in milk trans-16:1 and trans-18:1 content compared with the CPO diet. All rapeseed diets resulted in significant increases in cis-9 18:1, 18:2n-6 and 18:3n-3 intake when compared with the CPO diet, but there was no significant increase in milk fat trans-11 18:1 concentration, the major trans FA in milk fat that is a common intermediate formed during the penultimate step of PUFA biohydrogenation in the rumen (Harfoot and Hazlewood, 1997; Shingfield et al., 2010) . A lack of change in milk fat trans-11 18:1 content has been reported in cows fed milled rapeseeds even when a similar amount of lipid in the form of rapeseed oil enhanced the concentration of this biohydrogenation intermediate in milk (Givens et al., 2009) . Previous studies have also reported that ground rapeseeds have no effect (Collomb et al., 2004) or result in marginal increases in milk fat trans-11 18:1 concentrations (Chichlowski et al., 2005) .
In spite of cows consuming more PUFA on the COR than HOR treatments, there was no significant difference between rapeseed types with respect to trans-MUFA or total trans FAs in milk indicating that biohydrogenation of cis-9 18:1 as well as 18:2n-6 and 18:3n-3 in the rumen results in the formation and accumulation of substantial amounts of trans FAs that are incorporated into milk fat. Total trans-MUFA secretion in milk was more closely associated with cis-9 18:1 intake (R 2 5 0.785; y 5 0.05x 1 45.83) than with PUFA intake (R 2 5 0.528; y 5 0.09x 1 40.60). In vitro studies have shown that cis-9 18:1 is converted to a range of trans 18:1 isomers during incubation with rumen-derived microorganisms McKain et al., 2010) . In particular, around 70% to 100% of trans-7, trans-9, trans-10 and trans-12 18:1 were thought to originate from the isomerisation of cis-9 18:1 . Furthermore, trans-9 18:1 can be further isomerised during incubations with mixed rumen bacteria to yield a range of positional trans 18:1 isomers (Proell et al., 2002) . Supplying higher amounts of cis-9 18:1 in the diet in the form of the HOR supplement in this study resulted in a higher enrichment of trans-4, trans-5 and trans-6-8 18:1 in milk fat, and a numerical but non-significant (P 5 0.09) enrichment of milk trans-9 18:1 content compared with the COR diet. Earlier studies also reported a significant increase in milk trans-6-8, trans-9 18:1, trans-12, trans-13-14 and trans-16 18:1 in cows fed when rapeseed supplements were fed compared with a control diet (Collomb et al., 2004; Givens et al., 2009) .
Trans-7, cis-9 CLA is the second most abundant CLA isomer in bovine milk fat on most diets , that is synthesised exclusively via the action of D 9 desaturase on trans-7 18:1 in ruminant tissues (Corl et al., 2002; Piperova et al., 2002) . Enhanced concentrations of this isomer in milk fat following replacement of CPO with milled rapeseeds can be attributed to an increased availability of trans-7 18:1 at the mammary gland, following the formation of this intermediate during biohydrogenation of cis-9 18:1 in the rumen . Consistent with products formed during incubations of cis-9 18:1 with mixed rumen bacteria , HOR enhanced milk fat trans-6-8 18:1 content and resulted in numerically higher concentrations of trans-7, cis-9 CLA compared with COR treatments.
Milk fat cis-9, trans-13 18:2 content was substantially enhanced when rapeseed lipids replaced CPO in the diet. This FA is at least partially synthesised endogenously in the mammary gland via the action of D 9 -desaturase on trans-13 18:1 formed in the rumen . Both trans-13 18:1 and cis-9, trans-13 18:2 tend to increase following the feeding of 18:2n-6 or 18:3n-3 -rich plant oils (Collomb et al., 2004; Shingfield et al., 2008) . Including rapeseed lipids at the expense of CPO resulted in reduced concentrations of trans-8, trans-10 CLA and trans-9, trans-11 CLA in milk. Incubations of 18:2n-6 with mixed rumen microbes (Jouany et al., 2007) , measurements of FA flows at the omasum and milk FA composition in cows fed plant oils Rego et al., 2009) indicate that trans-8, trans-10 CLA and trans-9, trans-11 CLA accumulate in the rumen in direct relation to 18:2n-6 intake. The results of this study for milk fat CLA isomer concentrations appear to be consistent with the higher 18:2n-6 intake of cows fed diets containing milled rapeseeds than CPO.
In conclusion, replacing CPO with milled rapeseeds at inclusion levels up to 1150 g oil/day decreased milk fat SFA, enhanced milk cis-MUFA and increased trans FA concentrations without inducing adverse effects on DM intake and milk production. Use of a HOR variety induced larger decreases in milk fat SFA, increased (P , 0.001) the ratio of trans-MUFA : trans-PUFA and altered the relative abundance of specific trans FA isomers compared with isoenergetic amounts of CORs.
